Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

‘Weak’ evidence leads to NICE no for three leukaemia drugs

May 6, 2011 Sales and Marketing Glivec, NICE, Sprycel, Tasigna

NICE has not recommended three major drugs for the rare blood cancer chronic myeloid leukaemia. In draft guidance on treating …
News
Novartis' Afinitor (everolimus)

Novartis’ Afinitor wins landmark US approval

May 6, 2011 Sales and Marketing Afinitor, Novartis

Novartis’ Afinitor has been approved in the US for the treatment of progressive neuroendocrine tumours of pancreatic origin (PNET) in …
News

Ogilvy picks Carsten Edwards to lead new market access business

May 6, 2011 Medical Communications, Sales and Marketing Ogilvy, Ogilvy Healthworld Market Access, medical communications

Ogilvy Healthworld has appointed Carsten Edwards to head its new market access business. Edwards will be managing partner of market …
News

Prostate cancer drug Zytiga gains US approval

May 5, 2011 Sales and Marketing Centocor Ortho Biotech, Johnson & Johnson, Zytiga, prostate cancer

Zytiga a new treatment for the most hard to treat cases of prostate cancer has been approved in the US. …
News
Sanofi-Aventis' Plavix (clopidogrel)

Plavix sales plummet in England

May 5, 2011 Sales and Marketing BMS, Plavix, Sanofi-Aventis, clopidogrel

GP prescriptions for Plavix saw a significant drop in England last year as doctors opted for cheaper generic forms of …
News
Pfizer

Pfizer sales flat as Lipitor revenues decline

May 4, 2011 Sales and Marketing Pfizer

Pfizer’s sales decreased slightly in the first quarter after rising revenues in specialty care and emerging markets failed to offset …
News
ABPI Code of Practice

UK pharma reassured over dealings with health bodies

May 3, 2011 Medical Communications, Sales and Marketing 2011 ABPI Code, Code of Practice, medical communications, risk-sharing

UK pharma has been reassured over the use of risk-sharing schemes with health bodies. The latest revisions to the ABPI …
News

US approval for Boehringer’s diabetes drug Tradjenta

May 3, 2011 Sales and Marketing Boehringer Ingelheim, Tradjenta, diabetes, lilly

Tradjenta, the once-daily oral type II diabetes treatment developed by Boehringer Ingelheim, has been approved by US regulators. The FDA …
News
Cephalon

Cephalon accepts Teva’s $6.8 billion white knight bid

May 3, 2011 Research and Development, Sales and Marketing Cephalon, Teva, Valeant, generics

Generics giant Teva has acquired Cephalon for $6.8 billion and says the deal will make it a leading specialty pharmaceutical …
News
GlaxoSmithKline

GSK sales suffer double-digit drop

April 28, 2011 Sales and Marketing GSK, GlaxoSmithKline

GlaxoSmithKline saw a hefty drop in revenue in the first three months of this year as it struggled to contend …
News
idea_pharma_pankaj_oza

Pankaj Oza joins Idea Pharma

April 28, 2011 Sales and Marketing appointment, sales and marketing

Strategic consultancy Idea Pharma has appointed Pankaj Oza to its IDEAtion delivery team. He has over 20 years’ industry experience …
Appointment

Integrate: marketing and market access must come together

April 28, 2011 Sales and Marketing Drug pricing, market access, marketing

Although the words ‘market access’ have become much more commonplace in our working lives, the new clarity of its importance …
Feature

Photocure appoints new chief operating officer

April 28, 2011 Sales and Marketing appointment, sales and marketing

Kathleen Deardorff will join Norwegian specialist pharmaceutical company Photocure as chief operating officer on 1 May. She has over 25 …
Appointment
Caribbean tunicate Ecteinascidia turbinata

NICE gives final no to PharmaMar’s Yondelis

April 27, 2011 Sales and Marketing NICE, PharmaMar, Yondelis, ovarian cancer

A lack of evidence and an unconvincing patient access scheme has seen PharmaMar fail to win NICE backing for its …
News

Bayer defends Yasmin against BMJ studies

April 26, 2011 Sales and Marketing Bayer, Yasmin, contraception

Bayer has rallied strongly behind its top-selling contraceptive brand Yasmin after two studies in the British Medical Journal questioned the …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026